Trade Mark Journal No.2026/032 7 August 2026
WO0000001929459 (5,10,42,44)
Office of origin: United States of America
Date of International Registration:19 May 2026
Date of designation in the UK:
19 May 2026
International priority date claimed: 2 December 2025
(United States of America)
(99524753)
International priority date claimed: 2 December 2025
(United States of America)
(99524772)
International priority date claimed: 2 December 2025
(United States of America)
(99524775)
International priority date claimed: 2 December 2025
(United States of America)
(99524779)
- Class 5
- Cultures of microorganisms for medical or veterinary use; medical preparations for the treatment of wounds, aging, inflammation, and degenerative conditions; pharmaceutical and biological preparations for the treatment of wounds, aging, inflammation, and degenerative conditions; stem cells for medical purposes; chemical, biological, and diagnostic reagents for medical use; prepared cell culture media for clinical or medical purposes.
- Class 10
- Surgical apparatus and instruments for medical, dental, or veterinary use; injection needles for medical use; inhalers for medical use, sold empty; genetic testing apparatus for medical purposes; apparatus for DNA and RNA testing for medical purposes.
- Class 42
- Tissue engineering research; medical and scientific research services in the field of tissue engineering; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research and development in the fields of synthetic biology, molecular biology, genetic engineering, and bioinformatics; genetic mapping for scientific purposes; genetic testing of laboratory animals for research purposes; biomedical research services.
- Class 44
- Medical and pharmaceutical consultation; genetic testing for medical purposes; regenerative medicine services; DNA screening for medical purposes; provision of medical services by healthcare professionals via the internet or telecommunication networks; medical services; hygienic and beauty care services; genetic testing of animals for diagnostic or treatment purposes; diagnostic services, namely, medical testing for diagnostic or treatment purposes in the fields of aging, inflammation, degenerative conditions, and other diseases and disorders.
Axagon Bio, Inc.
Representative: Kristin S. Cornuelle Orrick, Herrington & Sutcliffe LLP, 2050 Main Street, Suite 1100, Irvine CA 92614, UNITED STATES OF AMERICA